Companies settle opioid lawsuits with state for $226M Oklahoma's recent settlement of four civil lawsuits arising from an ongoing national epidemic of opioid abuse and addiction will bring to more than $900 million the amount the state will receive from companies involved in the making, marketing and distribution of powerful painkillers like OxyContin, state Attorney General John O'Connor said. Lawsuits filed against pharmacy chains CVS, Walgreens and Walmart and against drugmaker Allergan were settled for $226.1 million. Oklahoma will receive $79.5 million from Walgreens, $73 million from CVS, $41 million from Walmart and $32.6 million from Allergan, O'Connor said. Previously, the state settled cases it had filed against Purdue Pharma, maker of OxyContin, for $270 million, against Teva Pharmaceuticals for $85 million, against Endo Pharmaceuticals for $8.75 million, and against distributors McKesson, Cardinal and AmerisourceBergen for more than $250 million.